Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 9,360.00
+250.00 (2.74%)
Apr 16, 2026, 12:15 PM KST
-34.91% (1Y)
| Market Cap | 109.50B -27.6% |
| Revenue (ttm) | 19.02B +224.2% |
| Net Income | 13.68B |
| EPS | 227.41 |
| Shares Out | 12.02M |
| PE Ratio | 40.06 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,678 |
| Average Volume | 93,680 |
| Open | 9,200.00 |
| Previous Close | 9,110.00 |
| Day's Range | 9,120.00 - 9,360.00 |
| 52-Week Range | 8,900.00 - 20,000.00 |
| Beta | 0.73 |
| RSI | 42.37 |
| Earnings Date | May 29, 2026 |